Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
Annals of Hematology
|
October 8, 2015
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy
M Postorino, L Pupo, I Provenzano, et al.
Bone Marrow Transplantation
|
August 16, 2016
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study
F Marchesi, A Tendas, D Giannarelli, et al.
Journal of Bone Oncology
|
December 11, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
O Annibali, M T Petrucci, D Santini, et al.
ESMO Open
|
March 12, 2026
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape
F Gay, G Buda, M T Petrucci, et al.
ESMO Open
|
January 8, 2025
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients
E A Martino, S Palmieri, M Galli, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
Annals of Hematology
|
October 8, 2015
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy
M Postorino, L Pupo, I Provenzano, et al.
Bone Marrow Transplantation
|
August 16, 2016
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study
F Marchesi, A Tendas, D Giannarelli, et al.
Journal of Bone Oncology
|
December 11, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
O Annibali, M T Petrucci, D Santini, et al.
ESMO Open
|
March 12, 2026
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape
F Gay, G Buda, M T Petrucci, et al.
ESMO Open
|
January 8, 2025
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients
E A Martino, S Palmieri, M Galli, et al.
Page
of 6